Biological staging indicates that 434 participants have acquired 591 matched sessions of data, each with a T1-weighted MRI, amyloid-PET, and tau-PET scan collected within 1 year, that are both amyloid and tau-PET negative. Here, MAPT is linked to amyloidosis.